Cytohub
- Biotech or pharma, therapeutic R&D
CytoHub (San Diego, CA) is scaling the flagship CardioVive™ platform, #1 human-based model for cardiac pharmacology, to dominate the market after the FDA's recent shift into non-animal-based models.
We're crafting cells for cures- developed an AI-powered enabling platform and are in pre-clinical development of cardiac cell therapy.
CytoHub is rapidly scaling its flagship CardioVive™ platform in San Diego, a best-in-class human-based therapeutic-enabling platform. In addition, our drug candidate is HeartReady™, which is in pre-clinical development.
Our vision is to revolutionize cardiac regenerative medicine with hypo-immune iPSC-derived cardiomyocytes that enable superior engraftment, immune evasion, and physiological function. Our AI-powered human mini-heart platform is transforming drug discovery, disease modeling, and heart muscle regeneration, paving the way for breakthrough therapies in cardiovascular care.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}